Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study - Concepedia

Concepedia

Publication | Open Access

Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study

DOI Full Paper Access

79

Citations

28

References

2020

Year

Houli Zhao, Jieping Wei, Guoqing Wei, Yi Luo, Jimin Shi, Qu Cui, Mingfeng Zhao, Aibin Liang, Qing Zhang, Jianmin Yang,

Journal of Hematology & Oncology

Abstract

The study was registered in the Chinese clinical trial registry (ChiCTR1900023957).

References

	Year	Citations

Page 1